First-line Biologic Coverage for STELARA®
As of January 2017, STELARA® is available on approximately 70% of commercial plans requiring no biologic step edits* with open access through several national plans and pharmacy benefit managers (PBMs).1†‡
*Requiring no step edits indicates a drug will be given first-line biologic access and will not require stepping through other biologic therapies.
†Including UnitedHealthcare® (UHC), UHC West®, OptumRx®, Aetna®, Anthem®, Express Scripts® National Preferred/Basic, and Humana® (medical benefit only) as of July 1, 2017.
‡Step edits required by biologic-naïve patients only.
Access support
to help you navigate payer processes
Affordability support
to help your patients start and stay on treatment you prescribe
Treatment support
to help your patients get informed and stay on prescribed treatment
Prescribe STELARA®
Complete the Prescription Enrollment Form and fax it to 855-224-5072
Connecting Your Commercially Insured Patients to Their Prescribed Treatment
When commercial insurance is delayed or denied,║ your eligible¶ patients will receive:
- STELARA® at no cost
-
Ongoing coverage until your patients receive coverage or through the rest of the current program year if an approval decision has not been made after 90 days#
This program is not available to individuals who use any state or federal government-subsidized healthcare program to cover a portion of medication costs, such as Medicare, Medicaid, TRICARE®, Department of Defense, or Veterans Administration, or any other federal or state healthcare plan, including pharmaceutical assistance programs. TRICARE® is a registered trademark of the Department of Defense (DoD), DHA.
§Patients may choose not to participate in Janssen Link. Janssen Biotech, Inc., reserves the right to cancel or modify Janssen Link at any time. Janssen CarePath cannot accept any information without an executed Business Associate Agreement or patient authorization, which can be found on the Prescription Information and Janssen Link Enrollment Form on file. In addition, a Prescription Information and Janssen Link Enrollment Form must be submitted for each patient for whom treatment with STELARA® is requested.
║Commercial insurance has been delayed >5 business days, or denied the treatment prescribed.
¶Payer must have a biologic fail/first policy in place, patient must verbally “opt-in” to participate.
#If prior authorization is denied after an appeal has been filed, eligible patients will receive STELARA® at no charge until the end of the current program year. Patients who begin participation in the program during the months of November or December will be approved through the following calendar year.
Enroll your office—1 time only
Complete the Program Enrollment Form and fax it to 855-224-5072
Prescribe STELARA®
Complete the Prescription Enrollment Form and fax it to 855-224-5072
Affordability support
Janssen CarePath Savings Program
Eligible commercial patients pay JUST $5 for each dose
Your patients get savings off their deductible, co-pay, and co-insurance medication costs for STELARA®
-
$20,000 maximum program benefit per calendar year
– For medication cost only; not available to patients who use any state or federal government-subsidized healthcare program to cover a portion of medication costs, such as Medicare, Medicaid, TRICARE®, Department of Defense (DoD), or Veterans Administration (VA); see full eligibility requirements at JanssenCarePath.com. TRICARE is a registered trademark of the DoD, DHA.
- Program does not cover cost of administering treatment
- No income requirement
Enrollment and activation at stelara.janssencarepathsavings.com or call 877-CarePath (877-227-3728).
Janssen Biotech, Inc., the maker of STELARA®, is not liable for unintended or unauthorized use of the STELARA® MasterCard® if it is lost or stolen. The Janssen CarePath Savings Program for STELARA® Prepaid MasterCard is issued by MetaBank®, Member FDIC, pursuant to license by MasterCard International Incorporated. MasterCard is a registered trademark of MasterCard International Incorporated. Janssen CarePath Savings Program is not a MetaBank product and is not endorsed by them.
Treatment support
Janssen Nurse Support—just a phone call away
- Janssen Nurse Support can help answer questions about giving an injection at home, preparing the injection site prior to self-injecting, and properly disposing of the used syringe
- Connect with Janssen Nurse Support at 877-CarePath (877-227-3728), available Monday to Friday, 9:00 AM to 8:00 PM ET.
- At all other times, a nurse will return your call in about 15 minutes
Online Patient Support
- A step-by-step guide to getting started with STELARA® for the approved indication of active psoriatic arthritis and the approved indication of moderate to severe plaque psoriasis is available online
- Patients can learn more about their STELARA® treatment at StelaraInfo.com
877-CarePath (877-227-3728)
Monday to Friday, 8:00 AM to 8:00 PM ET
JanssenCarePath.com
Reference: 1. Data on file. Janssen Biotech, Inc.